Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-08-04. The firm and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. The company has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.
Follow-Up Questions
Medivolve Inc (MEDVF)의 PER은 얼마입니까?
Medivolve Inc의 PER은 0입니다
MEDVF 주식의 가격 성능은 어떻습니까?
MEDVF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Medivolve Inc의 주요 사업 주제나 업종은 무엇입니까?
Medivolve Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
